Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App





Winners Announced of the 18th Healthcare Innovation World Cup at MEDICA 2026

By LabMedica International staff writers
Posted on 19 Nov 2026

The 18th Healthcare Innovation World Cup announced its winners at MEDICA 2026 in Düsseldorf, Germany, with Romania's . More...

lumen taking first place, followed by ROPHAI of the United States in second place and Belgium's Allow Motion in third place. .lumen also received the Public Vote award. Held on November 16 during the MEDICA INNOVATION FORUM, the competition attracted more than 300 submissions from over 60 countries, with 12 finalists presenting their healthcare innovations before an international jury.

The winning companies showcased technologies spanning assistive mobility, robotic blood collection, and advanced prosthetics, demonstrating the growing role of artificial intelligence (AI) and automation in healthcare.

.lumen (Cluj-Napoca, Romania) secured first place with its AI-powered smart glasses designed to help people who are blind navigate their surroundings independently. The wearable device uses computer vision, sensors, and AI to detect obstacles, identify walkable paths, and guide users through real-time haptic feedback. Based on the company's Pedestrian Autonomous Driving technology, the glasses translate information about the surrounding environment into tactile signals that direct users along safe routes without relying on continuous audio instructions. The system is designed to provide navigation assistance similar to some of the functions performed by guide dogs, supporting greater mobility and independence for people with visual impairments.

ROPHAI (Cambridge, MA, USA) took second place with its AI-enabled robotic phlebotomy system designed to automate aspects of blood collection. The investigational, human-assisted robotic device combines ultrasound imaging, machine learning, and robotic needle guidance to visualize blood vessels beneath the skin and identify suitable sites for venipuncture. Its AI technology analyzes vein location, diameter, and depth to support precise and repeatable needle placement. The system aims to reduce variability in blood collection, improve workflow efficiency, and help healthcare facilities address phlebotomy staffing shortages. ROPHAI has developed a working prototype and is preparing for regulatory submission, with the device not yet cleared for commercial clinical use.

Allow Motion (Seraing, Belgium) earned third place with its AI-powered myoelectric prosthetic hand technology, designed to provide more intuitive control for people with upper-limb amputations. The company's NeoHand prosthesis combines customized 3D-printed components with electronic sensors and AI algorithms that interpret signals from the user's muscles to recognize intended movements. The technology is designed to adapt to individual users, enabling more natural control of hand movements while improving comfort and functionality. By integrating additive manufacturing with intelligent control systems, Allow Motion aims to make advanced prosthetic solutions more personalized and accessible.

A special ST Innovation Challenge award went to Soterya (United States) for its AI-powered autonomous repositioning bed. The company's Korus platform uses sensing technologies and physical AI to monitor body positioning and automatically reposition individuals with limited mobility. The technology is being developed for home care, long-term care facilities, and hospital environments, with the aim of reducing caregiver workload and supporting patients who require regular repositioning.

The 2026 competition highlighted innovations in medical robotics, AI-enabled assistive technologies, patient monitoring, and connected healthcare. An international jury evaluated the finalists based on innovation, go-to-market strategy, commercial potential, and sustainability. The three leading companies will be inducted into the Innovation World Cup Hall of Fame and receive access to investor introductions, industry partnerships, technical guidance, and international networking opportunities through the MEDICA and Innovation World Cup networks.

Related Links
Innovation World Cup


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Led by Professor Sherry Chan Kit-wa (middle), the HKUMed research team provides the first large-scale Chinese population evidence to support reviewing Hong Kong’s long-term blood-monitoring requirements for clozapine use. (Photo courtesy of HKUMed)

Study Supports Review of Long-Term Blood-Monitoring Guidelines for Clozapine

Treatment-resistant schizophrenia (TRS) is a severe form of schizophrenia for which clozapine remains the only antipsychotic specifically approved by the U.S. Food and Drug Administration (FDA).... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image

Labcorp Partners With Grupo Fleury to Expand Clinical Trial Operations in Brazil

Multinational clinical trials require laboratory partners that combine global expertise with local operational capabilities. Brazil is an important clinical research destination, supported by its diverse... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.